Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Trial Evaluating Escalating Doses and the Safety of Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms

NCT03188991 is registered in ClinicalTrials.gov with NanOlogy, LLC as lead sponsor.

NCT NCT03188991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03188991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Trial Evaluating Escalating Doses and the Safety of Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms
Lead sponsor
NanOlogy, LLC
Phase
Phase 2
Overall status
Completed
Start date
September 29, 2017
Completion date
June 29, 2020
Enrollment
20 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic mucinous-cystic neoplasm